Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

The ice recrystallization inhibitor polyvinyl alcohol does not improve platelet cryopreservation.

Six KR, Lyssens S, Devloo R, Compernolle V, Feys HB.

Transfusion. 2019 Sep;59(9):3029-3031. doi: 10.1111/trf.15395. No abstract available.

PMID:
31483880
2.

Are we underestimating reverse TRALI?

De Clippel D, Emonds MP, Compernolle V.

Transfusion. 2019 Sep;59(9):2788-2793. doi: 10.1111/trf.15431. Epub 2019 Jun 26.

PMID:
31241780
3.

Hepatitis E virus prevalence in Flemish blood donors.

Vercouter AS, Van Houtte F, Verhoye L, González Fraile I, Blanco L, Compernolle V, Meuleman P.

J Viral Hepat. 2019 Oct;26(10):1218-1223. doi: 10.1111/jvh.13161. Epub 2019 Jul 24.

PMID:
31194897
4.

Impact of cold storage on platelets treated with Intercept pathogen inactivation.

Six KR, Devloo R, Compernolle V, Feys HB.

Transfusion. 2019 Aug;59(8):2662-2671. doi: 10.1111/trf.15398. Epub 2019 Jun 12.

PMID:
31187889
5.

Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis.

Van Remoortel H, Moorkens D, Avau B, Compernolle V, Vandekerckhove P, De Buck E.

Vox Sang. 2019 May;114(4):297-309. doi: 10.1111/vox.12780. Epub 2019 Apr 10.

PMID:
30972765
6.

A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device.

Six KR, Sicot G, Devloo R, Feys HB, Baruch D, Compernolle V.

Vox Sang. 2019 May;114(4):330-339. doi: 10.1111/vox.12776. Epub 2019 Mar 21.

PMID:
30900265
7.

Comparison between manufacturing sites shows differential adhesion, activation, and GPIbα expression of cryopreserved platelets.

Six KR, Delabie W, Devreese KMJ, Johnson L, Marks DC, Dumont LJ, Compernolle V, Feys HB.

Transfusion. 2018 Nov;58(11):2645-2656. doi: 10.1111/trf.14828. Epub 2018 Oct 12.

PMID:
30312492
8.

Biomolecular Consequences of Platelet Pathogen Inactivation Methods.

Feys HB, Van Aelst B, Compernolle V.

Transfus Med Rev. 2019 Jan;33(1):29-34. doi: 10.1016/j.tmrv.2018.06.002. Epub 2018 Jun 27. Review.

9.

Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentrates.

Feys HB, Devloo R, Sabot B, Coene J, Compernolle V.

Vox Sang. 2018 May 24. doi: 10.1111/vox.12668. [Epub ahead of print]

PMID:
29797720
10.

Post-transfusion hemoglobin values and patient blood management.

Moerman J, Vermeulen E, Van Mullem M, Badts AM, Lybeert P, Compernolle V, Georgsen J.

Acta Clin Belg. 2019 Jun;74(3):164-168. doi: 10.1080/17843286.2018.1475939. Epub 2018 May 17.

PMID:
29770734
11.

Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline.

Compernolle V, Chou ST, Tanael S, Savage W, Howard J, Josephson CD, Odame I, Hogan C, Denomme G, Shehata N; International Collaboration for Transfusion Medicine Guidelines.

Transfusion. 2018 Jun;58(6):1555-1566. doi: 10.1111/trf.14611. Epub 2018 Apr 26. Review.

PMID:
29697146
12.

Importance of information provision in the acceptance of blood donation criteria by the general public in Belgium.

Avau B, De Buck E, Vandekerckhove P, Compernolle V.

Blood Transfus. 2018 Nov;16(6):475-482. doi: 10.2450/2017.0151-17. Epub 2017 Nov 27.

13.

Phylogenetic analysis reveals three distinct epidemiological profiles in Dutch and Flemish blood donors with hepatitis B virus infection.

van de Laar TJ, Van Gaever VA, Swieten PV, Muylaert A, Compernolle V, Zaaijer HL.

Virology. 2018 Feb;515:243-249. doi: 10.1016/j.virol.2017.12.011. Epub 2018 Jan 8.

14.

Glucocorticoid receptor DNA methylation and childhood trauma in chronic fatigue syndrome patients.

Vangeel EB, Kempke S, Bakusic J, Godderis L, Luyten P, Van Heddegem L, Compernolle V, Persoons P, Lambrechts D, Izzi B, Freson K, Claes S.

J Psychosom Res. 2018 Jan;104:55-60. doi: 10.1016/j.jpsychores.2017.11.011. Epub 2017 Nov 20.

PMID:
29275786
15.

Is an endoscopic examination associated with transfusion-transmissible infections? A systematic review and meta-analysis.

Van Remoortel H, Borra V, De Buck E, Compernolle V, Vandekerckhove P.

Transfusion. 2018 Feb;58(2):507-519. doi: 10.1111/trf.14416. Epub 2017 Nov 30. Review.

PMID:
29194668
16.

High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis.

Feys HB, Devloo R, Sabot B, De Pourcq K, Coene J, Compernolle V.

Vox Sang. 2017 Nov;112(8):751-758. doi: 10.1111/vox.12596. Epub 2017 Sep 27. Erratum in: Vox Sang. 2018 Oct;113(7):708.

PMID:
28960339
17.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):e48-e68. doi: 10.1111/vox.12523. Epub 2017 Sep 14. No abstract available.

PMID:
28905396
18.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):680-683. doi: 10.1111/vox.12522. Epub 2017 Sep 14. No abstract available.

PMID:
28905391
19.

Phylogenetic evidence for underreporting of male-to-male sex among human immunodeficiency virus-infected donors in the Netherlands and Flanders.

van de Laar TJ, Bezemer D, van Laethem K, Vandewalle G, de Smet A, van Wijngaerden E, Claas EC, van Sighem AI, Vandamme AM, Compernolle V, Zaaijer HL.

Transfusion. 2017 May;57(5):1235-1247. doi: 10.1111/trf.14097. Epub 2017 Apr 4.

PMID:
28375576
20.

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time.

Six KR, Devloo R, Van Aelst B, Vandekerckhove P, Feys HB, Compernolle V.

J Vis Exp. 2017 Feb 14;(120). doi: 10.3791/55351.

21.

Hemoglobin screening in blood donors: a prospective study assessing the value of an invasive and a noninvasive point-of-care device for donor safety.

De Clippel D, Van Heddegem L, Vandewalle G, Vandekerckhove P, Compernolle V.

Transfusion. 2017 Apr;57(4):938-945. doi: 10.1111/trf.13987. Epub 2017 Feb 6.

PMID:
28168852
22.

The effect of a standard whole blood donation on oxygen uptake and exercise capacity: a systematic review and meta-analysis.

Van Remoortel H, De Buck E, Compernolle V, Deldicque L, Vandekerckhove P.

Transfusion. 2017 Feb;57(2):451-462. doi: 10.1111/trf.13893. Epub 2016 Nov 3. Review.

PMID:
27807869
23.

Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing.

Van Aelst B, Devloo R, Zachée P, t'Kindt R, Sandra K, Vandekerckhove P, Compernolle V, Feys HB.

J Biol Chem. 2016 Nov 18;291(47):24364-24376. Epub 2016 Sep 29.

24.

International forum: an investigation of iron status in blood donors.

Vuk T, Magnussen K, De Kort W, Folléa G, Liumbruno GM, Schennach H, Vandewalle G, Compernolle V, Masharova N, Karakatsiani G, Argyrou I, Řeháček V, Khanirzajeva G, Castrén J, Danic B, Djoudi R, Woimant G, Mueller MM, Politis C, Vaglio S, Daugavvanaga A, Vilutytė E, Faber JC, Borg-Aquilina D, Van Den Burg P, Bokhorst A, Pogłód R, Antoniewicz-Papis J, Muon M, Burta OL, Rosochová J, Mali P, Vesga MA, Schneider K, Norda R, Anderson N.

Blood Transfus. 2017 Jan;15(1):20-41. doi: 10.2450/2016.0101-16. Epub 2016 Sep 7. No abstract available.

25.

International Forum regarding practices related to donor haemoglobin and iron.

Goldman M, Magnussen K, Gorlin J, Lozano M, Speedy J, Keller A, Pink J, Leung JN, Chu CC, Lee CK, Faed J, Chay J, Tan HH, Teo D, Djoudi R, Woimant G, Fillet AM, Castrén J, Miflin G, Vandewalle GC, Compernolle V, Cardenas JM, Infanti L, Holbro A, Buser A, van den Hurk K, Yahalom VJ, Gendelman V, Shinar E, Eder AF, Steele WR, O'Neill EM, Kamel H, Vassallo R, Delage G, Lebrun A, Robillard P, Germain M, Gandhi M, West KA, Klein HG.

Vox Sang. 2016 Nov;111(4):449-455. doi: 10.1111/vox.12431. Epub 2016 Aug 26. No abstract available.

PMID:
27564140
26.

Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation.

Feys HB, Pottel H, Coene J, Vandewalle G, Vandekerckhove P, Compernolle V.

Vox Sang. 2016 Nov;111(4):431-433. doi: 10.1111/vox.12437. Epub 2016 Aug 10.

PMID:
27509321
27.

Evaluation of the intercept oral specimen collection device with HIV assays versus paired serum/plasma specimens.

Beelaert G, Van Heddegem L, Van Frankenhuijsen M, Vandewalle G, Compernolle V, Florence E, Fransen K.

J Virol Methods. 2016 Aug;234:164-8. doi: 10.1016/j.jviromet.2016.04.014. Epub 2016 Apr 30.

PMID:
27142112
28.

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro.

Van Aelst B, Feys HB, Devloo R, Vandekerckhove P, Compernolle V.

J Vis Exp. 2016 Mar 19;(109). doi: 10.3791/53823.

29.

The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates.

Feys HB, Van Aelst B, Devloo R, Vandekerckhove P, Compernolle V.

Vox Sang. 2016 May;110(4):344-51. doi: 10.1111/vox.12365. Epub 2015 Dec 8.

PMID:
26646710
30.

Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds.

Van Remoortel H, De Buck E, Dieltjens T, Pauwels NS, Compernolle V, Vandekerckhove P.

Transfusion. 2016 Feb;56(2):472-80. doi: 10.1111/trf.13385. Epub 2015 Nov 6. Review.

PMID:
26545702
31.

Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro.

Van Aelst B, Devloo R, Vandekerckhove P, Compernolle V, Feys HB.

Transfusion. 2015 Oct;55(10):2404-14. doi: 10.1111/trf.13137. Epub 2015 Apr 25.

PMID:
25912149
32.

Is having sex with other men a risk factor for transfusion-transmissible infections in male blood donors in Western countries? A systematic review.

De Buck E, Dieltjens T, Compernolle V, Vandekerckhove P.

PLoS One. 2015 Apr 15;10(4):e0122523. doi: 10.1371/journal.pone.0122523. eCollection 2015.

33.

Persistent aggregates in apheresis platelet concentrates.

Feys HB, Coene J, Devloo R, Van Aelst B, Pottel H, Vandekerckhove P, Compernolle V.

Vox Sang. 2015 May;108(4):368-77. doi: 10.1111/vox.12243. Epub 2015 Mar 6.

PMID:
25754290
34.

Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.

Van Aelst B, Feys HB, Devloo R, Vanhoorelbeke K, Vandekerckhove P, Compernolle V.

Vox Sang. 2015 May;108(4):328-39. doi: 10.1111/vox.12231. Epub 2014 Dec 30.

PMID:
25557250
35.

Aggregates in platelet concentrates.

van der Meer PF, Dumont LJ, Lozano M, Bondar N, Wong J, Ismay S, Pink J, Nussbaumer W, Coene J, Feys HB, Compernolle V, Devine DV, Howe D, Lin CK, Sun J, Ringwald J, Strasser EF, Eckstein R, Seltsam A, Perseghin P, Proserpio P, Wakamoto S, Akino M, Takamoto S, Tadokoro K, Teo D, Shu PH, Chua SS, Jimenez-Marco T, Lozano M, Cid J, Castro E, Muñoz I, Gulliksson H, Sandgren P, Thomas S, Petrik J, McColl K, Kamel H, Dugger J, Sweeney JD, Gorlin JB, Sutor LJ, Heath D, Sayers MH.

Vox Sang. 2015 Jan;108(1):96-100. doi: 10.1111/vox.12184. Epub 2014 Sep 19. No abstract available.

PMID:
25234238
36.

Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.

De Clippel D, Baeten M, Torfs A, Emonds MP, Feys HB, Compernolle V, Vandekerckhove P.

Transfusion. 2014 Dec;54(12):3036-42. doi: 10.1111/trf.12727. Epub 2014 May 27.

PMID:
24863861
37.

The effect of pre-donation hypotension on whole blood donor adverse reactions: a systematic review.

Pauwels NS, Cusack L, De Buck E, Compernolle V, Vandekerckhove P.

J Am Soc Hypertens. 2014 Jun;8(6):429-36. doi: 10.1016/j.jash.2014.03.332. Epub 2014 Apr 5. Review.

PMID:
24856084
38.

Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.

Lieberman L, Devine DV, Reesink HW, Panzer S, Wong J, Raison T, Benson S, Pink J, Leitner GC, Horvath M, Compernolle V, Prado Scuracchio PS, Wendel S, Delage G, Nahirniak S, Dongfu X, Krusius T, Juvonen E, Sainio S, Cazenave JP, Guntz P, Kientz D, Andreu G, Morel P, Seifried E, Hourfar K, Lin CK, O'Riordan J, Raspollini E, Villa S, Rebulla P, Flanagan P, Teo D, Lam S, Ang AL, Lozano M, Sauleda S, Cid J, Pereira A, Ekermo B, Niederhauser C, Waldvogel S, Fontana S, Desborough MJ, Pawson R, Li M, Kamel H, Busch M, Qu L, Triulzi D.

Vox Sang. 2014 Oct;107(3):276-311. doi: 10.1111/vox.12103. Epub 2014 May 7. No abstract available.

PMID:
24801438
39.

Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction.

Coene J, Devreese K, Sabot B, Feys HB, Vandekerckhove P, Compernolle V.

Transfusion. 2014 May;54(5):1321-31. doi: 10.1111/trf.12460. Epub 2013 Oct 22.

PMID:
24472023
40.

Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.

Feys HB, Van Aelst B, Devreese K, Devloo R, Coene J, Vandekerckhove P, Compernolle V.

Vox Sang. 2014 May;106(4):307-15. doi: 10.1111/vox.12106. Epub 2013 Oct 29.

PMID:
24460692
41.

Should DEHP be eliminated in blood bags?

van der Meer PF, Reesink HW, Panzer S, Wong J, Ismay S, Keller A, Pink J, Buchta C, Compernolle V, Wendel S, Biagini S, Scuracchio P, Thibault L, Germain M, Georgsen J, Bégué S, Dernis D, Raspollini E, Villa S, Rebulla P, Takanashi M, de Korte D, Lozano M, Cid J, Gulliksson H, Cardigan R, Tooke C, Fung MK, Luban NL, Vassallo R, Benjamin R.

Vox Sang. 2014 Feb;106(2):176-95. doi: 10.1111/vox.12099. Epub 2013 Dec 12. No abstract available.

PMID:
24330039
42.

Evaluation of 6 years of confidential unit exclusion at the Belgian Red Cross Flanders Blood Service.

Vandewalle G, Baeten M, Bogaerts K, Vandekerckhove P, Compernolle V.

Vox Sang. 2014 May;106(4):354-60. doi: 10.1111/vox.12115. Epub 2013 Nov 30.

PMID:
24289738
43.

Blood type diets lack supporting evidence: a systematic review.

Cusack L, De Buck E, Compernolle V, Vandekerckhove P.

Am J Clin Nutr. 2013 Jul;98(1):99-104. doi: 10.3945/ajcn.113.058693. Epub 2013 May 22. Review.

PMID:
23697707
44.

Worldwide policies on haemochromatosis and blood donation: a survey among blood services.

Pauwels NS, De Buck E, Compernolle V, Vandekerckhove P.

Vox Sang. 2013 Aug;105(2):121-8. doi: 10.1111/vox.12038. Epub 2013 May 11.

PMID:
23663183
45.

Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage.

Feys HB, Vandekerckhove P, Compernolle V.

Transfusion. 2013 Jan;53(1):233-4. doi: 10.1111/j.1537-2995.2012.03925.x. No abstract available.

PMID:
23294212
46.

Is blood of uncomplicated hemochromatosis patients safe and effective for blood transfusion? A systematic review.

De Buck E, Pauwels NS, Dieltjens T, Compernolle V, Vandekerckhove P.

J Hepatol. 2012 Nov;57(5):1126-34. doi: 10.1016/j.jhep.2012.04.040. Epub 2012 May 30. Review.

47.

Prophylactic platelet transfusions.

Pietersz RN, Reesink HW, Panzer S, Gilbertson MP, Borosak ME, Wood EM, Leitner GC, Rabitsch W, Ay C, Lambermont M, Deneys V, Sondag D, Compernolle V, Legrand D, François A, Tardivel R, Garban F, Sawant RB, Rebulla P, Handa M, Ohto H, Kerkhoffs JL, Brand A, Zhiburt E, Cid J, Escolar G, Lozano M, Puig L, Knutson F, Hallböök H, Lubenow N, Estcourt L, Stanworth S, Murphy MF, Williams L, Mraz DL, Ross RL, Snyder E.

Vox Sang. 2012 Aug;103(2):159-76. doi: 10.1111/j.1423-0410.2012.01595.x. Epub 2012 Apr 20. No abstract available.

PMID:
22519879
48.
49.

Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation.

Cowden Dahl KD, Fryer BH, Mack FA, Compernolle V, Maltepe E, Adelman DM, Carmeliet P, Simon MC.

Mol Cell Biol. 2005 Dec;25(23):10479-91.

50.

Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha.

Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, Collen D, Carmeliet P.

Cardiovasc Res. 2003 Dec 1;60(3):569-79.

PMID:
14659802

Supplemental Content

Loading ...
Support Center